EUVIMEDTutustu EUVIMEDiin
Crossref

Effectiveness of a Triple Antiarrhythmic Drug Strategy for Arrhythmia Recurrence after Persistent Atrial Fibrillation Ablation

Shuyu Jin iD, Haowei Chen, Xianhong Fang, Hongtao Liao, Xianzhang Zhan, Lu Fu, Junrong Jiang, Xingdong Ye, Huiyi Liu, Yanlin Chen, Sijia Pu, Shulin Wu iD and 3 more

Pacing and Clinical Electrophysiology · 2024

DOI: 10.1111/pace.15083 ↗

At a glance

Journal article in Pacing and Clinical Electrophysiology, 2024. Written by Shuyu Jin and 14 co-authors. Institution: Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Souther…. Major MEDLINE topics: Atrial Fibrillation, Anti-Arrhythmia Agents, Recurrence, Propafenone. Cited 2 times so far (Crossref); 31 references. Funded by: National Natural Science Foundation of China, Guangdong Provincial Department of Science and Technology, Guangdong special funds for science and technology innovation strategy, China.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background and objective Treating recurrent atrial arrhythmias after persistent atrial fibrillation (PeAF) ablation is often challenging. This single‐center, prospective study aimed to observe the effectiveness of different combinations of oral antiarrhythmic drugs (AADs) in reverting to sinus rhythm (SR) in patients with recurrent atrial arrhythmias after PeAF ablation.

Methods

Forty‐five patients who experienced recurrent atrial arrhythmias after PeAF ablation were included. Based on their medication regimens, patients were divided into two groups, with the study group being a triple‐drug group (digoxin combined with amiodarone/ propafenone and β‐blocker), and the control group being a non‐triple‐drug group.

Results

The rate of reversion to SR was significantly higher in the study group ( n = 29) than in the control group ( n = 16) at 3 weeks (34.48% vs. 0%, p < 0.01) and 1 month (44.84% vs. 6.25%, p = 0.02) after initiating AADs. No patients with asymptomatic bradycardia were observed in either group.

Conclusions

For patients with recurrent atrial arrhythmias after PeAF ablation, a regimen of low‐dose digoxin combined with amiodarone/propafenone and β‐blocker may effectively improve short‐term reversion rates.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationAnti-Arrhythmia AgentsRecurrencePropafenoneCatheter AblationAmiodaroneDrug Therapy, CombinationHumansMaleFemaleMiddle AgedProspective StudiesTreatment OutcomeDigoxinAdrenergic beta-AntagonistsAged

Author keywords

ablationantiarrhythmic drugspersistent atrial fibrillationrecurrencesinus rhythm

Substances

Anti-Arrhythmia AgentsPropafenoneAmiodaroneDigoxinAdrenergic beta-Antagonists

Authors and institutions

  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.

ORCID profiles: Shuyu Jin, Shulin Wu, Yumei Xue

Funding

  • National Natural Science Foundation of China
  • Guangdong Provincial Department of Science and Technology
  • Guangdong special funds for science and technology innovation strategy, China
  • Zhongnanshan medical foundation of Guangdong Province

Cite

APA

Jin, S., Chen, H., Fang, X., Liao, H., Zhan, X., Fu, L., Jiang, J., Ye, X., Liu, H., Chen, Y., Pu, S., Wu, S., Deng, H., Lin, W., & Xue, Y. (2024). Effectiveness of a Triple Antiarrhythmic Drug Strategy for Arrhythmia Recurrence after Persistent Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.15083

Vancouver

Jin S, Chen H, Fang X, Liao H, Zhan X, Fu L, et al. Effectiveness of a Triple Antiarrhythmic Drug Strategy for Arrhythmia Recurrence after Persistent Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. 2024. doi:10.1111/pace.15083

BibTeX
@article{Jin2024,
  author = {Jin, Shuyu and Chen, Haowei and Fang, Xianhong and Liao, Hongtao and Zhan, Xianzhang and Fu, Lu and Jiang, Junrong and Ye, Xingdong and Liu, Huiyi and Chen, Yanlin and Pu, Sijia and Wu, Shulin and Deng, Hai and Lin, Weidong and Xue, Yumei},
  title = {Effectiveness of a Triple Antiarrhythmic Drug Strategy for Arrhythmia Recurrence after Persistent Atrial Fibrillation Ablation},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2024},
  doi = {10.1111/pace.15083}
}
Start for free →